Chemocentryx Book Value per Share Trend from 2010 to 2021

CCXI -  USA Stock  

USD 15.32  0.21  1.39%

Chemocentryx Book Value per Share is decreasing over the last several years with slightly volatile swings. Book Value per Share is predicted to flatten to 5.30. During the period from 2010 to 2021 Chemocentryx Book Value per Share regressed destribution of quarterly values had coefficient of variationof 121.47 and r-value of (0.58). Chemocentryx Interest Expense is most likely to increase significantly in the upcoming years. The last year's value of Interest Expense was reported at 2.64 Million. The current Selling General and Administrative Expense is estimated to increase to about 45.5 M, while Consolidated Income is projected to decrease to (56.8 M).

Search Historical Trends 

 
Refresh
Check Chemocentryx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemocentryx main balance sheet or income statement drivers, such as Gross Profit of 54.5 M, Interest Expense of 2.9 M or Operating Expenses of 98.9 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0482, PPandE Turnover of 4.86 or Receivables Turnover of 446. Chemocentryx financial statements analysis is a perfect complement when working with Chemocentryx Valuation or Volatility modules. It can also supplement various Chemocentryx Technical models. Continue to the analysis of Chemocentryx Correlation against competitors.

Chemocentryx Quarterly Book Value per Share

5.186Share

Chemocentryx Book Value per Share Breakdown

Showing smoothed Book Value per Share of Chemocentryx with missing and latest data points interpolated. Measures the ratio between Shareholders Equity and [SharesWA] as adjusted by [ShareFactor].Chemocentryx's Book Value per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemocentryx's overall financial position and show how it may be relating to other accounts over time.
Book Value per Share10 Years Trend
Decreasing
Slightly volatile
 Book Value per Share 
Share
      Timeline 

Chemocentryx Book Value per Share Regression Statistics

Arithmetic Mean 5.25
Geometric Mean 2.85
Coefficient Of Variation 121.47
Mean Deviation 4.50
Median 3.12
Standard Deviation 6.38
Sample Variance 40.70
Range 18.51
R-Value(0.58)
Mean Square Error 29.92
R-Squared 0.33
Significance 0.05
Slope(1.02)
Total Sum of Squares 447.65

Chemocentryx Book Value per Share History

2011  18.05 
2012  3.12 
2013  3.55 
2014  2.51 
2015  1.65 
2016  1.07 
2017  1.64 
2018  0.30 
2019  1.16 
2020  5.87 
2021  5.30 

Other Fundumenentals of Chemocentryx

Chemocentryx Book Value per Share component correlations

About Chemocentryx Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Chemocentryx income statement, its balance sheet, and the statement of cash flows. Chemocentryx investors use historical funamental indicators, such as Chemocentryx's Book Value per Share, to determine how well the company is positioned to perform in the future. Although Chemocentryx investors may use each financial statement separately, they are all related. The changes in Chemocentryx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chemocentryx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Chemocentryx Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Chemocentryx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Book Value per Share 5.87  5.30 
Tangible Assets Book Value per Share 7.90  7.31 
Enterprise Value4.3 B4.6 B
Tangible Asset Value518.9 M559.9 M
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chemocentryx without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Money Managers Now

   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Module

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Edesa Biotech. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to the analysis of Chemocentryx Correlation against competitors. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.